Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» AZD1775
AZD1775
AstraZeneca drug heads to phase 2 in pancreatic cancer after small trial extends survival
Fierce Biotech
Thu, 08/15/19 - 12:27 pm
AstraZeneca
pancreatic cancer
DNA
University of Michigan
AZD1775